A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with type 1 diabetes mellitus with persistent sub-optimal glycaemic control: A diabetes and psychological therapies (ADaPT) study

Health Technology Assessment

Volumn 14, Issue 22, 2010, Pages 1-127

  Ismail, K ^a   Maissi, E ^a   Thomas, S ^b   Chalder, T ^a   Schmidt, U ^a   Bartlett, J ^c   Patel, A ^a   Dickens, C ^d   Creed, F ^d   Treasure, J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MOTIVATIONAL ENHANCEMENT THERAPY; NURSE; OUTCOME ASSESSMENT; PATIENT CARE; PROFESSIONAL COMPETENCE; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANXIETY; ATTITUDE TO HEALTH; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; ECONOMICS; FEMALE; GLYCEMIC INDEX; HEALTH SURVEY; HEMOGLOBINURIA; MALE; MIDDLE AGED; MOTIVATION; PROCEDURES; PSYCHOLOGIC TEST; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANXIETY; COGNITIVE THERAPY; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; DEPRESSION; DIABETES MELLITUS, TYPE 1; FEMALE; GLYCEMIC INDEX; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINURIA; HUMANS; INTERVIEW, PSYCHOLOGICAL; LOGISTIC MODELS; MALE; MIDDLE AGED; MOTIVATION; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953342237     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta14220     Document Type: Article

References (218)

1. Edge J, Ford-Adams M, Dunger D. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child 1999;81:318-23.
2. Daneman D. Type 1 Diabetes. Lancet 2006;367: 847-58.
3. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
4. Karvonen I, Viik-Kajander M, Moltchanova E, Libman I, Laporte R, Tuomilehto J, et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000;23:1516-26.
5. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999;42:1395-403.
6. National Institute for Health and Clinical Excellence. Type 1 diabetes: management of type 1 diabetes in children, young people and adults in primary and secondary care. London: National Institute for Health and Clinical Excellence, 2004.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
8. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulindependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177-88.
9. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996;19:195-203.
10. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research G. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. N Engl J Med 2005;353: 2643-53.
11. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Research Group. Retinopathy and nephropathy in patients with Type 1 Diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-9.
12. Mühlhauser I, Jorgens V, Berger M, Graninger W, Gurtler W, Hornke L, et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983;25:476.
13. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325:746-9.
14. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705.
15. Wiseman A, Gill R. The continuing progress and challenges of clinical islet transplantation. Diabetes and the endocrine pancreas II. Curr Opin Endocrinol Diabetes Obes 2005;12:291-7.
16. DeVries J, Snoek F, Heine R. Persistent poor glycaemic control in adult Type 1 diabetes. A closer look at the problem. Diabet Med 2004;21:1263-8.
17. Davies M. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges. Int J Obes 2004;28(Suppl. 2):S14-S22.
18. Gulliford M, Ashworth M, Robotham D, Mohiddin A. Achievement of metabolic targets for diabetes in English general practice under a new system of incentives. Diabet Med 2007;24:505-11.
19. Bryden K, Peveler R, Stein A, Neil A, Mayou R, Dunger D. Clinical and psychological course of diabetes from adolescence to young adulthood. Diabetes Care 2001;24:1536-40.
20. Geddes J, McGeough E, Frier B. Young adults with Type 1 diabetes in tertiary education: do students receive adequate specialist care? Diabet Med 2006;23:1155-7.
21. Dahlquist G, Kallen B, on behalf of the Swedish Childhood Diabetes Study Group. School performance in children with type 1 diabetes - a population-based register study. Diabetalogia 2007;50:957-64.
22. Department of Health. National Service Framework for Diabetes: Standards. 2001. URL: www.dh.gov.uk/en/Healthcare/NationalServiceFrameworks/Diabetes/index.htm (accessed 25 July 2008).
23. Chaturvedi N, Stephenson J, Fuller J. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM complications study. Diabetes Care 1996;19:423-30.
24. Jorgens V, Bott U, Muhlhauser I, Berger M. Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 1993;36:99-105.
25. Bott U, Jorgens V, Grusser M, Bender R, Muhlhauser I, Berger M. Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 1994;11:362-71.
26. Orchard T, Dorman J, Maser R, Becker D, Drash A, Ellis D, et al. Prevalence of complications in IDDM by sex and duration - Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1990;39:1116-24.
27. Lloyd C, Klein R, Maser R, Kuller L, Becker D, Orchard T. The progression of retinopathy over 2 years: The Pittsburgh Epidemiology of Diabetes Complications (EDC) study. J Diabetes Complications 1995;9:140-8.
28. Delahanty L, Halford B. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial. Diabetes Care 1993;16:1453-8.
29. Taylor M, Frier B, Gold A, Deary I. Psychosocial factors and diabetes-related outcomes following diagnosis of Type 1 diabetes in adults: the Edinburgh Prospective Study. Diabet Med 2003;20:135-46.
30. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
31. Anderson R, Freedland K, Clouse R, Lustman P. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
32. Lustman P, Griffith L, Clouse R. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care 1988;11:605-12.
33. Peyrot M, Rubin R. Persistence of depressive symptoms in diabetic adults. Diabetes Care 1999;22:448-52.
34. Peyrot M, Rubin R. Levels and risks of depression and anxiety symptomology among diabetic adults. Diabetes Care 1997;20:585-90.
35. Egede L, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 2003;26:104-11.
36. Engum A, Mykletun A, Midthjell K, Holen A, Dahl A. Depression and Diabetes: A large populationbased study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 2005;28:1904-9.
37. Fisher L, Chesla C, Mullan J, Skaff M, Kanter R. Contributors to depression in Latino and European- American patients with type 2 diabetes. Diabetes Care 2001;24:1751-7.
38. Lustman P, Anderson R, Freedland K, de Groot M, Carney R, Clouse R. Depression and poor glycaemic control. A meta-analytic review of the literature. Diabetes Care 2000;23:934-42.
39. de Groot M, Anderson R, Freedland K, Clouse R, Lustman P. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63:619-30.
40. Jacobson A, de Groot M, Samson J. The effects of psychiatric disorders and symptoms on quality of life in patients with Type 1 and Type 2 diabetes mellitus. Qual Life Res 1997;6:11-20.
41. Black S, Markides K, Ray L. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003;26:2822-8.
42. Katon W, Rutter C, Simon G, Lin E, Ludman E, Ciechanowski P, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005;28:2668-72.
43. Zhang X, Norris S, Gregg E, Cheng Y, Beckles G, Kahn H. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005;161:652-60.
44. Egede L, Nietert P, Zheng D. Depression and allcause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005;28:1339-45.
45. Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with diabetes and their first foot ulcer: The role of depression on mortality. Diabetes Care 2007;30:1473-9.
46. Grigsby A, Anderson R, Freedland K, Clouse R, Lustman P. Prevalence of anxiety in adults with diabetes: A systematic review J Psychosom Res 2002;53:1053-60.
47. Anderson R, De Groot M, Grigsby A, McGill J, Freedland K, Clouse R. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatr Med 2002;32:235-47.
48. Ciechanowski P, Katon W, Russo J. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-85.
49. Lustman P, Clouse R, Nix B, Freedland K, Rubin E, McGill J, et al. Sertraline for prevention of depression recurrence in diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Arch Gen Psych 2006;63:521-9.
50. Lustman P, Freedland K, Griffith L, Clouse R. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000;23:618-23.
51. Lustman P, Griffith L, Clouse R, Freedland K, Eisen S, Rubin E, et al. Effects of nortriptyline on depression and glycaemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997;59:241-50.
52. Lustman P, Griffith L, Freedland K, Kissel S, Clouse R. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Int Med 1998;129:613-21.
53. Katon W, Von Korff M, Lin E, Simon G, Ludman E, Russo J, et al. The Pathways Study: A randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004;61:1042-9.
54. Lin E, Katon W, Rutter C, Simon G, Ludman E, Von Korff M, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med 2006;4:46-53.
55. Williams J, Katon W, Lin E, Noel P, Worchel J, Cornell J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004;140:1015-24.
56. Peveler RC, Fairburn CG, Boller I, Dunger DB. Eating disorders in adolescents with IDDM: a controlled study. Diabetes Care 1992;15:1356-60.
57. Jones J, Lawson M, Daneman D, Olmstead M, Rodin G. Eating disorders in adolescents females with and without type 1 diabetes: cross sectional study. BMJ 2000;320:1563-6.
58. Mannucci E, Rotella F, Ricca V, Moretti S, Placidi G, Rotella C. Eating disorders in patients with Type 1 diabetes: A meta-analysis. J Endocrinological Invest 2005;28:417.
59. Rydall AC, Rodin GM, Olmstead MP, Devenyi RG, Daneman D. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997;336:1849-54.
60. Peveler R, Bryden K, Neil A, Fairburn C, Mayou R, Dunger D, et al. The relationship of disordered eating habits and attitudes to clinical outcomes in young adult females with type 1 diabetes. Diabetes Care 2005;28:84-8.
61. Bienvenu O, Eaton W. The epidemiology of bloodinjection- injury phobia. Psychol Med 1998;28: 1129-36.
62. Mollema E, Snoek F, Ader H, Heine R, van der Ploeg H. Insulin-treated diabetes patients with fear of self-injecting or fear of self testing. Psychological comorbidity and general well-being. J Psychosom Res 2001;51:665-72.
63. Nordfeld S, Ludvigsson J. Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metabol 2005;18:83-91.
64. Cox D, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation and utilization. Diabetes Care 1987;10:617-21.
65. Irvine A, Cox D, Gonder-Frederick L. Fear of hypoglycaemia: relationship to physical and psychological symptoms in patients with insulindependent diabetes mellitus. Health Psychol 1992;11:135-38.
66. Karlsen B, Bru E, Hanestad B. Self-reported psychological well-being and disease-related strains among adults with diabetes. Psychol Health 2002;17:459-73.
67. Wredling R, Theorell P, Roll H, Lins P, Adamson U. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care 1992;15:518-21.
68. Polonsky W. Diabetes burnout: What to do when you can't take it anymore. American Diabetes Association, Alexandria, VA; 2000.
69. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1990;8:217-22.
70. Meltzer D, Egleston B. How patients with diabetes perceive their risk for major complications. Eff Clin Pract 2000;3:7-15.
71. Snoek F, Skinner T. Psychological counselling in problematic diabetes: does it help? Diabet Med 2002;19:265-73.
72. Ciechanowski P, Russo J, Katon W, Von Korff M, Ludman E, Lin E, et al. Influence of patient attachment style on self-care and outcomes in diabetes. Psychosom Med 2004;66:720-8.
73. Ong L, Dehaes J, Hoos A, Lammes F. Doctor- Patient Communication - a review of the literature. Soc Sci Med 1995;40:903-18.
74. Piette J, Valenstein M. Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. Am J Manag Care 2004;10:152-62.
75. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, et al. A systematic review of controlled trials of the effectiveness and costeffectiveness of brief psychological treatments for depression. Health Technol Assess 2001;5(35).
76. Hodes M, Moorey S. Psychological treatment in disease and illness. London: Gaskell, 1993.
77. Assal J, Mühlhauser I, Pernet A, Gfeller R, Jörgens V, Berger M. Patient education as the basis for diabetes care in clinical practice and research Diabetalogia 1985;28:602-13.
78. Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice Hall, 1986.
79. Albano M, Jacquemet S, Assal J. Patient education and diabetes research: a failure! Going beyond the empirical approaches. Acta Diabetologica 1998;35:207-14.
80. Daniels G. Present trends in the evaluation of psychic factors in diabetes mellitus: A critical review of experimental, general medical and psychiatric literature of the last five years. Psychosom Med 1939;1:527-52.
81. Moran G, Fonagy P, Kurtz A, Bolton A, Brook C. A controlled study of the psychoanalytic treatment of brittle diabetes. J Am Acad Child Adolesc Psychiatry 1991;30:926-35.
82. Hampson S, Skinner T, Hart J, Storey L, Gage H, Foxcroft D, et al. Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess 2001;5(10).
83. Norris S, Engelgau M, Venkat Naryan K. Effectiveness of self-management training in type 2 diabetes. A systematic review of randomized controlled trials. Diabetes Care 2001;24:561-87.
84. Winkley K, Landau S, Eisler I, Ismail K. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 2006;333:65-71.
85. Rogers C. Client centred psychotherapy. London: Constable, 1976.
86. Miller W, Sovereign G, Kree B. Motivational interviewing with problem drinkers: II, The drinkers check-up as a preventative intervention. Behavioural Psychotherapy 1988;16:251-68.
87. Beck A. Cognitive therapy and the emotional disorders. New York, NY: Meridian., 1976.
88. Meichenbaum D. Cognitive-behavior modification: An integrative approach. New York, NY: Plenum, 1977.
89. Malan D. A study of brief psychotherapy. London: Plenum Press, 1963.
90. Klerman G, Weissman M, Rounsaville B, Chevron E. Interpersonal psychotherapy of depressions. New York, NY: Basic Books, 1984.
91. Bateman A, Brown D, Pedder J. Introduction to psychotherapy: an outline of psychodynamic principles and practice. London: Routledge, 2000.
92. Minuchin S. Families and family therapy. London: Routledge, 1991.
93. Moorey S, Williams R. Behavioural and cognitive therapies. In: Murray R, Hill P, McGuffin P, editors. The essentials of postgraduate psychiatry. Cambridge: Cambridge University Press, 1997.
94. Hawton K, Salkovskis P, Kirk J, Clark D. Cognitive behaviour therapy for psychiatric problems: A practical guide. Oxford: Oxford Medical Publications, 1989.
95. Miller W, Rollnick S. Motivational interviewing: preparing people to change addictive behaviour. New York, NY: Guildford Press, 1991.
96. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-9.
97. Feinglos M, Hastedt P, Surwit R. Effects of relaxation therapy on patients with Type 1 diabetes mellitus. Diabetes Care 1987;10:72-5.
98. Fosbury J, Bosley CM, Ryle A, Sonksen P, Judd S. A trial of cognitive-analytical therapy in poorly controlled Type 1 patients. Diabetes Care 1997;20:959-64.
99. Weinger K, Schwartz E, Davis A, Rodriguez M, Simonson D, Jacobson A. Cognitive behavioral treatment in Type 1 diabetes: A randomized controlled trial. Abstract from the American Diabetes Association 62nd Scientific Sessions. Diabetes 2002;51(Suppl. 2):A439.
100. van der Ven N, Lubach C, Hogenelst M, van Iperen A, Tromp-Wever A, Vriend A, et al. Cognitive behavioural group training (CBGT) for patients with type 1 diabetes in persistent poor glycaemic control: who do we reach? Patient Educ Couns 2005;56:313-22.
101. Spiess K, Sachs G, Pietschmann P, Prager R. A program to reduce onset distress in unselected type 1 diabetic patients:effects on psychological variables and metabolic control. Eur J Endocrinol 1995;132:580-6.
102. Didjurgeit U, Kruse J, Schmitz N, Stuckenschnieder P, Sawicki P. A time-limited, problem-orientated psychotherapeutic intervention in Type 1 diabetic patients with complications: a randomized controlled trial. Diabet Med 2002;19:814-21.
103. Manning R, Jung R, Leese G, Newton R. The comparison of four weight reduction strategies aimed at overweight diabetic patients. Diabet Med 1994;12:409-15.
104. Glasgow R, Toobert D, Hampson S. Effects of a brief office-based intervention to facilitate diabetes dietary self-management. Diabetes Care 1996;19:835-42.
105. 1c and the patient's evaluation of the quality of diabetes care: a randomized controlled trial. Diabetes Care 2001;24:1929-35.
106. Carroll K, Nuro K. One size can't fit all: A stage model for psychotherapy manual development. Clin Psychol Sci Pract 2002;9:396-406.
107. Waltz J, Addis M, Koerner K, Jacobson N. Testing the integrity of a psychotherapy protocol: assessment of adherence and competence. J Consult Clin Psychol 1993;61:620-30.
108. Goldfried M, Wolfe B. Towards a more clinically valid approach to therapy research. J Consult Clin Psychol 1998;66:143-50.
109. Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 2000;22:858-71.
110. Halford W, Goodall T, Nicholson J. Diet and diabetes (II): a controlled trial of problem solving to improve dietary self-management in patients with insulin dependent diabetes. Psychol Health 1997;12:231-8.
111. Van der Ven N, Hogenelst M, Tromp-Wever A, Twisk J, der Ploeg H, Heine R, et al. Short-term effects of cognitive behavioural group training (CBGT) in adult Type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial. Diabet Med 2005;22:1619-23.
112. Department of Health and the Medical Research Council. Current and future research on diabetes. London: Department of Health, 2002.
113. Medical Research Council. A framework for the development and evaluation of randomised controlled trials for complex interventions to improve health. London: MRC, 2000.
114. Miller W, Rollnick S. Motivational interviewing: preparing people to change addictive behaviour. 2nd edition. New York, NY: Guildford Press, 2002.
115. Project MATCH Research group. Project MATCH: Rationale and methodsfor a multisite clinical trial matching alcoholism patients to treatment. Alcohol Clin Exp Res 1993;17:1130-45.
116. Miller W, Benefield R, S T. Enhancing motivation for change in problem drinking: a controlled comparison of two therapist styles. J Consult Clin Psychol 1993;61:455-61.
117. The Accu-Check Interview software program. Boston, MA: Joslin Diabetes Center, 2000.
118. Miller W, Moyers T, Ernst D, Amrhein P. Manual for the Motivational Interviewing Skill Code. Version 2.0. 2003. URL: casaa.unm.edu/download/misc.pdf.
119. Schmidt U, Treasure J. Getting better bit(e) by bit(e): A survival kit for sufferers of bulimia nervosa and binge eating disorders. London: Psychology Press, 1993.
120. Treasure J. Motivational interviewing. Adv Psychiatr Treat 2004;10:331-7.
121. Festinger L. A theory of cognitive dissonance. Evaston, IL: Row Peterson, 1957.
122. Bem D. An experimental analysis of self-persuasion. J Exp Soc Psychol 1965;1:199-218.
123. Bem D. Self-perception theory. In: Berkowitz L, editor. Advances in experimental social psychology. New York, NY: Academic Press, 1972: 1-62.
124. Prochaska J, DiClemente C. Stages and processes of self-change of smoking:towards a more integrative model of change. J Consult Clin Psychol 1982;51: 390-5.
125. Prochaska J, DiClemente C, Norrcross J. In search of how people change: Applications to addictive behaviors. Am Psychol 1992;47:1102-14.
126. King B, Janis I. Comparison of the effectiveness of improvised vs non-improvised role-playing in producing opinion change. Hum Relat 1956;9: 177-86.
127. Scott W. Attitude change through reward of verbal behaviour. J Abnorm Soc Psychol 1957;55:72-5.
128. DiClemente C, Velasquez M. Motivational interviewing and the stages of change (second edition). In: ISRaWRM, editor. Motivational interviewing. New York, NY: Guilford Press, 2002: 201-15.
129. McConnaughy E, Prochaska J, Velicer W. Stages of change in psychotherapy: Measurement and sample profiles. Psychotherapy: Theory, Research and Practice 1983;20:368-75.
130. Rollnick S, Heather N, Bell A. Negotiating behavior change in medical settings: the development of brief motivational interviewing. J Ment Health 1992;1:25-37.
131. Prochaska J, Redding C, Evers K. The transtheoretical model and stages of change. In: Glanz K, Lewis FM, Rimer BK, editor. Health behavior and health education: Theory, research and practice. San Francisco, CA: Jossey-Bass, 2002.
132. Belding M, Iguchi M, Lamb R. Stages and processes of change as predictors of drug use among methadone maintenance patients. Exp Clin Psychopharmacol 1997;5:65-73.
133. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977;84:191-215.
134. Littell J, Girvin H. Stages of change: a critique. Behav Modif 2002;26:223-73.
135. Wilson G, Schlam T. The transtheoretical model and motivational interviewing in the treatment of eating and weight disorders. Clin Psychol Rev 2004;24:361-78.
136. Project MATCH Research Group. Matching alcoholism treatments to client heterogeniety: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997;58:7-29.
137. Trigwell P, Grant P, House A. Motivation and glycaemic control in diabetes mellitus. J Psychosom Res 1997;43:307-15.
138. Treasure J, Katzman M, Schmidt U, Troop N, Todd G, de Silva P. Engagement and outcome in the treatment of bulimia nervosa: First phase of a sequential design comparing motivation enhancement therapy and cognitive behavioural therapy. Behav Res Ther 1999;37:405-18.
139. Burke B, Arkowitz H, Mencola M. The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003;71:843-61
140. Gollwitzer P. Implementation intentions: strong effects of simple plans. Am Psychol 1999;54:493-503.
141. Hettema J, Steele J, Miller W. Motivational interviewing. Ann Rev Clin Psychol 2005;1:91-111.
142. Rogers R. Cognitive and physiological processes in fear appeals and attitude change: A revised theory of protection motivation. In: Cacioppo B, Petty L, editors. Social psychophysiology: A sourcebook. London: Guildford, 1983: 153-76.
143. Ajzen I, Madden T. Prediction of goal-directed behavior: Attitude, intentions, and perceived behavioral control. J Exp Soc Psychol 1986;22: 453-74.
144. Dunn C, Deroo L, Rivara F. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001;96:1725-42.
145. Rubak S, Sandbæk A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Practice 2005;55:305-12.
146. Viner R, Christie D, Taylor V, Hey S. Motivational/solution-focused intervention improves HbA1c in adolescents with Type 1 diabetes: a pilot study. Diabet Med 2003;20:739-42.
147. Channon S, Huws-Thomas M, Rollnick S, Hood K, Cannings-John R, Rogers C, et al. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care 2007;30:1390-5.
148. Clark M, Hampson S, Avery L, Simpson R. Effects of a tailored lifestyle self-management intervention in patients with type 2 diabetes. Br J Health Psychol 2004;9:365-79.
149. West DS, DiLillo V, Bursac Z, Gore S, Greene P. Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care 2007;30:1081-7.
150. Beck A. Thinking and depression: I. Idiosyncratic content and cognitive distortions. Arch Gen Psychiatry 1963;9:324-33.
151. Beck J. Cognitive therapy: basics and beyond. New York, NY: Guildford Press, 1995.
152. Lang P. Stimulus control, response control, and the desensitisation of fear. In: Lewis D, editor. Learning approaches to therapeutic behaviour. Chicago, IL: Aldine Press, 1970.
153. Lang P, Bradley M, Cuthbert B. Emotion, motivation, and anxiety: Brain mechanisms and psychophysiology. Biol Psychiatry 1998;44:1248-63.
154. Hugdahl K. The three systems model of fear and emotion - a critical examination. Behav Res Ther 1981;19:75-85.
155. Padesky C. Schema change processes in cognitive therapy. Clin Psychol Psychother 1994;1:267-78.
156. Leahy R. Overcoming resistance in cognitive therapy. New York, NY: Guildford Press, 2001.
157. Bowlby J. Attachment and Loss. Vol. III: Loss: sadness and depression. London: Hogarth, 1980.
158. Goldfried M, Robins C. Self-schema, cognitive bias, and the processing of therapeutic experiences. In: Kendall P, editor. Advances in cognitive-behavioral research and therapy. New York, NY: Academic Press, 1983: 33-80.
159. Castonguay L, Hayes A, Goldfried M, DeRubeis R. The focus of therapist interventions in cognitive therapy for depression. Cognit Ther Res 1995;19:485-503.
160. National Institute for Clinical Excellence. Depression: Management in primary and secondary care. London: National Institute for Clinical Excellence, 2004.
161. Ebmeier K, Donaghey C, Steele J. Recent developments and current controversies in depression. Lancet 2006;367:153-67.
162. Middleton H, Shaw I, Hull S, Feder G. NICE guidelines for the management of depression. BMJ 2005;330:267-8.
163. Hunot V, Churchill R, Silva de Lima M, Teixeira V. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev 2007;(1).
164. Price J, Cooper J. Cognitive behaviour therapy for adults with chronic fatigue syndrome. Cochrane Database Syst Rev 2000;(2).
165. National Institute for Clinical Excellence and Health. Eating disorders-core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders, NICE Clinical Guideline no 9. London: NICE, 2004.
166. York J, Fleming S, Shulman C. Psychological interventions for adults with asthma: A systematic review. Respir Med 2007;101:1-14.
167. Sharpe L, Sensky T, Timberlakec N, Ryanc B, Brewina C, Allard S. A blind, randomized, controlled trial of cognitive-behavioural intervention for patients with recent onset rheumatoid arthritis: preventing psychological and physical morbidity. Pain 2001;89:275-83.
168. Longabaugh R, Zweben A, Locastro J, Miller W. Origins, issues and options in the development of the combined behavioral intervention. J Stud Alcohol Suppl 2005:179-87.
169. Moher D, Schulz K, Altman D, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Ann Intern Med 2001;134:657-62.
170. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance, 1999.
171. Irvine A, Cox S, Conder-Frederick L. Methodological issues in the examination of fear of hypoglycaemia. Diabetes Care 1990;14:76.
172. Toobert D, Hampson S, Glasgow R. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 2000;23:943-50.
173. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing cognitive representations of medication. Psychol Health 1999;14:1-24.
174. Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD. The PHQ primary care study: primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 1999;282:1737-44.
175. Diabetes Control and Complications Trial Research Group. Reliability and validity of a diabetes quality of life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988;11:725-32.
176. Schafer J. Analysis of incomplete multivariate data. Boca Raton, FL: Chapman & Hall/CRC, 1997.
177. Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics 1996;52:1324-33.
178. King L. The health benefits of writing about life goals. Pers Soc Psychol Bull 2001;27:798-807.
179. Pennebaker J, Francis M. Cognitive, emotional and language process in disclosure. Cogn Emot 1996;10:601-26.
180. Pennebaker J, Seagal J. Forming a story: the health benefits of narrative. J Clin Psychol 1999;55: 1243-54.
181. Amrhein P, Miller W, Yahne C, Palmer M, Fulcher L, Franciosi M. Client commitment language during motivational interviewing predicts drug use outcomes. J Consult Clin Psychol 2003;71:862-78.
182. Kanfer F, Schefft B. Guiding the process of therapeutic change. Champaign, IL: Research Press, 1988.
183. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. Windsor: NFER-NELSON, 1988.
184. Moyers T, Marin T, Manuel J, Miller W. The motivational interviewing treatment integrity MITI code. Version 2.0. 2003. URL: casaa.unm.edu/download/miti.pdf.
185. Blackburn IM, Bishop S, Glen AI, Whalley LJ, Christie JE. The efficacy of cognitive therapy in depression: a treatment trial using cogntive therapy and pharmocotherapy each alone and in combination. Br J Psychiatry 1981;139:181-9.
186. Padesky C, Mooney K. Presenting the cognitive model to clients. International Cognitive Therapy Newsletter 1990;6:13-14.
187. Padesky C. Developing cognitive therapist competency: teaching and supervision models. In: Salkovskis P, editor. Frontiers of cognitive therapy. New York, NY: Guilford Press, 1996.
188. Moyers T, Miller W, Hendrickson S. How does motivational interviewing work? Therapist interpersonal skill predicts client involvement within motivational interviewing sessions. J Consult Clin Psychol 2005;73:590-8.
189. Moyers T, Martin T, Catley D, Harris K, Ahluwalia J. Assessing the integrity of motivational interviewing interventions: Reliability Of the Motivational Interviewing Skills Code. Behav Cogn Psychother 2003;31:177-84.
190. Center on Alcoholism SAaA. MITI Transcript. Motivational interviewing professional training videotape series. Alberquerque, NM: Center on Alcoholism, Substance Abuse and Addictions, 1998.
191. Efron B, Tibshirani R. An introduction to Bootstrap. New York, NY: Chapman & Hall, 1993.
192. Heeren T, D'Agostino R. Robustness of the two independent samples t-test when applied to ordinal scaled data. Stat Med 1987;6:79-90.
193. Miller W, Mount K. A small study of training in motivational interviewing:does one workshop change clinician and client behavior?. Behav CognPsychother 2001;29:457-71.
194. Moyers T, Martin T, Manuel J, Hendrickson S, Miller W. Assessing competence in the use of motivational interviewing. J Subst Abuse Treat 2005;28:19-26.
195. Shaw B, Elkin I, Yamaguchi J, Olmsted M, Vallis T, Dobson K, et al. Therapist competence ratings in relation to clinical outcome in cognitive therapy of depression. J Consult Clin Psychol 1999;67:837-46.
196. Reichelt F, James I, Blackburn I. Impact of training on rating competence in cognitive therapy. J Behav Ther Exp Psychiatry 2003;34:87-99.
197. Carroll K, Ball S, Nich C, Martino S, Frankforter T, Farentinos C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug Alcohol Depend 2006;81:301-12.
198. Beecham J, Knapp M. Costing psychiatric interventions. London: Gaskell, 1992.
199. Ware J, Sherbourne C. The MOS 36-item Short- Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
200. EuroQol Group. EuroQol: a facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
201. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of Health Econ 2002;21:271-92.
202. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol:results from a UK population survey. Discussion Paper 138. York: University of York, 1995.
203. Assmann S, Pocock S, Enos L, Kasten L. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355:1064-9.
204. Department of Health. Prescription cost analysis: England. London: Department of Health, 2006.
205. Briggs A. A Bayesian approach to stochastic costeffectiveness analysis. Health Econ 1999;8:257-61.
206. Rawlins M, Culyer T. National Institute for Clinical Excellence and its value judgements. BMJ 2004;329:224-7.
207. Wagner E, Sandhu N, Newton K, McCulloch D, Ramsey S, Grothaus L. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285:182-9.
208. Sholomskas D, Syracuse-Siewert G, Rounsaville B, Ball S, Nuro K, Carroll K. We don't train in vain: A dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol 2005;73:106-15.
209. Lackner J, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review & metaanalysis. J Consult Clin Psychol 2004;72:1100-13.
210. Miller WR. COMBINE Monograph Series, Volume 1. Combined behavioural intervention manual: a clinical research guide for therapists treating alcohol abuse or dependence. DHSS Publication no (NIH)04-5288. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 2004.
211. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2005;28: S4-36.
212. Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, et al. A Randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 2005;62:290-8.
213. Tang T, DeRubeis R. Sudden gains and critical sessions in cognitive behavioural therapy for depression. J Consult Clin Psychol 1999;67:894-904.
214. Scott J, Watkins E. Brief psychotherapies for depression: current status. Curr Opin Psychiatry 2004;17:3-7.
215. Lane C, Huws-Thomas M, Hood K, Rollnick S, Edwards K, Robling M. Lane, C., Huws-Thomas, M. V., Hood, K., Rollnick, S., Edwards, K., & Robling, M. (2005). Measuring adaptations of motivational interviewing: the development and validation of the behavior change counseling index (BECCI). Patient Education and Counseling, 56(2), 166-173. Patient Educ Couns 2005;56:166-73.
216. Montori V, Gandhi G, Guyatt G. Patient-important outcomes in diabetes: time for consensus. Lancet 2007;370:1104-6.
217. Whitfield G, Hinshelwood R, Pashely A, Campsie L, Williams C. The Impact of a Novel Computerized CBT CD Rom (Overcoming Depression) Offered to Patients Referred to Clinical Psychology. Behav Cogn Psychother 2006;34:1-11.
218. Sacco W, Morrison A, Malone J. A brief, regular, proactive telephone "coaching" intervention for diabetes: Rationale, description, and preliminary results. J Diabetes Complications 2004;18:113-18.